Patrick Weiss - Jul 21, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Operating Officer
Signature
/s/ William Solis, as Attorney-in-Fact for Patrick Weiss
Stock symbol
TWST
Transactions as of
Jul 21, 2021
Transactions value $
-$495,498
Form type
4
Date filed
7/23/2021, 04:30 PM
Previous filing
Jul 6, 2021
Next filing
Jul 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $18.6K +2.1K +4.15% $8.82 52.8K Jul 21, 2021 Direct
transaction TWST Common Stock Options Exercise $52.6K +1.97K +3.74% $26.66 54.8K Jul 21, 2021 Direct
transaction TWST Common Stock Options Exercise $20.7K +827 +1.51% $25.02 55.6K Jul 21, 2021 Direct
transaction TWST Common Stock Sale -$587K -4.91K -8.81% $119.75* 50.7K Jul 21, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -2.1K -25% $0.00 6.31K Jul 21, 2021 Common Stock 2.1K $8.82 Direct F2
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1.97K -3.33% $0.00 57.2K Jul 21, 2021 Common Stock 1.97K $26.66 Direct F3
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -827 -3.33% $0.00 24K Jul 21, 2021 Common Stock 827 $25.02 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020.
F2 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F3 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F4 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.